Blog examines coordinated effort to monitor drug procurement through Global Fund grants in Kyrgyzstan

NewsGuard 100/100 Score

"In recent years, Kyrgyzstan has benefited from a significant increase in international funding to improve health care," but, "[d]espite this influx of international funding, many people in Kyrgyzstan are unable to get the lifesaving medicines that they need," Madina Tokombaeva, director of the Harm Reduction Network (HRN) in Kyrgyzstan, and Maryam Beishenova, program coordinator at HRN, write in this Open Society Foundations blog post. The authors describe how, in 2010, "three Kyrgyz organizations working on HIV and health issues -- the Harm Reduction Network, Partnership Network, and Unity of People Living with HIV -- launched a coordinated effort to monitor and analyze the procurement and distribution of medicines purchased with Global Fund grants." They recount a court victory in which they gained access to Ministry of Health records and conclude, "Civil society organizations have been energized and we are committed to ensure that government agencies and donors are transparent and efficient" (4/5).


    http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.

    You might also like...
    Study reveals increased risk of immune abnormalities in children of women with HIV